Effects of resveratrol on the expression and DNA methylation of cytokine genes in diabetic rat aortas

Archivum Immunologiae et Therapiae Experimentalis

Volumn 62, Issue 4, 2014, Pages 329-340

  Lou, Xu Dan ^a   Wang, Hai Dong ^a,b   Xia, Shi Jin ^a,c   Skog, Sven ^d   Sun, Jiao ^a  

^a FUDAN UNIVERSITY   (China)

^b Diabetes Association of Administration and Education   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d Sino Swed Molecular Bio Medicine Research Institute   (China)

Author keywords

DNA methylation; Inflammatory cytokines; Resveratrol

Indexed keywords

CYTOSINE; GAMMA INTERFERON; GLUCOSE; GUANOSINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PHOSPHATE; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKENING; ARTERY INTIMA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA METHYLATION; DRUG MECHANISM; EPIGENETICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; AORTA; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; TH1 TH2 BALANCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTA; CYTOKINES; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; TH1-TH2 BALANCE;

EID: 84904328367     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-014-0271-4     Document Type: Article

References (56)

1. Armenante F, Merola M, Furia A et al (1999) Repression of the IL-6 gene is associated with hypermethylation. Biochem Biophys Res Commun 258:644-647 (Pubitemid 29290322)
2. Baur JA, Pearson KJ, Price NL et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342 (Pubitemid 44764104)
3. Bonilla-Henao V, Martínez R, Sobrino F et al (2005) Different signaling pathways inhibit DNA methylation activity and up-regulate IFN-gamma in human lymphocytes. J Leukoc Biol 78:1339-1346 (Pubitemid 41779240)
4. Brasacchio D, Okabe J, Tikellis C et al (2009) Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58:1229-1236
5. Burnett C, Valentini S, Cabreiro F et al (2011) Absence of effects of Sir2 over-expression on lifespan in C. elegans and drosophila. Nature 477:482-485
6. Campión J, Milagro FI, Goyenechea E et al (2009) TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity 17:1293-1297
7. Chen ZX, Riggs AD (2011) DNA methylation and demethylation in mammals. J Biol Chem 286:18347-18353
8. Cordero P, Campion J, Milagro FI et al (2011) Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem 67:463-470
9. Dogan Y, Akarsu S, Ustundag B et al (2006) Serum IL-1β, IL-2, and IL-6 in insulin-dependent diabetic children. Mediators Inflamm 2006:59206
10. Ekstrom TJ, Stenvinkel P (2009) The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications? J Nephrol 22:442-449
11. Fisman EZ, Adler Y, Tenenbaum A (2008) Biomarkers in cardiovascular diabetology: interleukins and matrixins. Adv Cardiol 45:44-64
12. Fuks F (2005) DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 15:490-495
13. Gopisetty G, Ramachandran K, Singal R (2006) DNA methylation and apoptosis. Mol Immunol 43:1729-1740
14. Hashimoto K, Otero M, Imagawa K et al (2013) Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1b (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J Biol Chem 288:10061-10072
15. Ingrosso D, Perna AF (2009) Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim Biophys Acta 1790:892-899
16. Jing YH, Chen KH, Yang SH et al (2010) Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling. Diabetes Metab Res Rev 26:212-222
17. Juan ME, Vinardell MP, Planas JM et al (2002) The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 132:257-260 (Pubitemid 34135604)
18. Keating ST, El-Osta A (2012) Chromatin modifications associated with diabetes. J Cardiovasc Transl Res 5:399-412
19. Keyes MK, Jang H, Mason JB et al (2007) Older age and dietary folate are determinants of genomic and p16-specific DNA methylation in mouse colon. J Nutr 137:1713-1717 (Pubitemid 47037696)
20. Krause B, Sobrevia L, Casanello P (2009) Epigenetics: new concepts of old phenomena in vascular physiology. Curr Vasc Pharmacol 7:513-520
21. Ku JL, Jeon YK, Park JG (2011) Methylation-specific PCR. Methods Mol Biol 791:23-32
22. Kubista M, Andrade JM, Bengtsson M et al (2006) The real-time polymerase chain reaction. Mol Aspects Med 27:95-125
23. Kuroda A, Rauch TA, Todorov I et al (2009) Insulin gene expression is regulated by DNA methylation. PLoS One 4:e6953
24. Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122 (Pubitemid 44894520)
25. Li LC, Dahiya R (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18:1427-1431
26. Li P, Zhao Y, Wu X et al (2012) Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription. Nucleic Acids Res 40:1609-1620
27. Ling C, Del Guerra S, Lupi R et al (2008) Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51:615-622
28. Liu Y, Biarnés Costa M, Gerhardinger C (2012) IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation. PLoS One 7:e36949
29. Mallat Z, Heymes C, Ohan J et al (1999) Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19:611-616 (Pubitemid 29135162)
30. Miao F, Gonzalo IG, Lanting L et al (2004) In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279:18091-18097 (Pubitemid 38560579)
31. Miranda TB, Jones PA (2007) DNA methylation: the nuts and bolts of repression. J Cell Physiol 213:384-390 (Pubitemid 47509717)
32. Mukamal KJ, Conigrave KM, Mittleman MA et al (2003) Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348:109-118 (Pubitemid 36056717)
33. Palsamy P, Subramanian S (2011) Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 1812:719-731
34. Park JH, Stoffers DA, Nicholls RD et al (2008) Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 118:2316-2324 (Pubitemid 351872348)
35. Pereira DS, Garcia DM, Narciso FM et al (2011) Effects of 174 G/C polymorphism in the promoter region of the interleukin-6 gene on plasma IL-6 levels and muscle strength in elderly women. Braz J Med Biol Res 44:123-129
36. Petro TM (2005) Disparate expression of IL-12 by SJL/J and B10.S macrophages during Theiler's virus infection is associated with activity of TLR7 and mitogen-activated protein kinases. Microbes Infect 7:224-232
37. Pirola L, Balcerczyk A, Tothill RW et al (2011) Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 21:1601-1615
38. Poussier B, Cordova AC, Becquemin JP et al (2005) Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg 42:1190-1197
39. Reddy MA, Natarajan R (2011) Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res 90:421-429
40. Schmatz R, Perreira LB, Stefanello N et al (2012) Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 94:374-383
41. Soufi FG, Vardyani M, Sheervalilou R et al (2012) Long-term treatment with resveratrol attenuates oxidative stress proinflammatory mediators and apoptosis in streptozotocin-nicoti-namide- induced diabetic rats. Gen Physiol Biophys 31:431-438
42. Szalmás A, Bánáti F, Koroknai A et al (2008) Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells. Eur J Cancer 44:1030-1038
43. Tekpli X, Landvik NE, Anmarkud KH et al (2013) DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell. Cancer Immunol Immunother 62:337-345
44. Tonna S, El-Osta A, Cooper ME et al (2010) Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms. Nat Rev Nephrol 6:332-341
45. Viana MB, Cardoso FP, Diniz MG et al (2011) Methylation pattern of IFN-γ and IL-10 genes in periodontal tissues. Immunobiology 216:936-941
46. Villeneuve LM, Natarajan R (2010) The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 299:F14-F25
47. Villeneuve LM, Reddy MA, Natarajan R (2011) Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol 38:451-459
48. Vlassara H, Palace MR (2002) Diabetes and advanced glycation end-products. J Intern Med 251:87-101
49. Wang H, Sun J, Xia S (2009a) Construction of the retrovirus vectors carrying the IL-17 or siRNA-IL-17 genes and expression of IL-17 gene in the transgenic diabetogenic T cells. Chin Gerontol J 29:2873-2877
50. Wang H, Sun J, Xia S (2009b) Interleukin-17 mediates the pathogenesis of diabetes induced by diabetogenic T lymphocytes in NOD mice. Chin J Endocrinol Metab 25:539-543
51. Wilson AG (2008) Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 79(8 Suppl):1514-1519
52. Wong YT, Gruber J, Jenner AM et al (2011) Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice. Age 33:229-246
53. Wren JD, Garner HR (2005) Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes. J Biomed Biotechnol 2005:104-112 (Pubitemid 41627866)
54. Yang Z, Chen M, Wu R et al (2002) Suppression of autoimmune diabetes by viral IL-10 gene transfer. J Immunol 168:6479-6485 (Pubitemid 34620073)
55. Zhang D, Jiang X, Fang P et al (2009a) Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation 120:1893-1902
56. Zhang H, Zhang J, Ungvari Z et al (2009b) Resveratrol improves endothelial function role of TNF-α and vascular oxidative stress. Arterioscler Thromb Vasc Biol 29:1164-1171